Webster AL,Yan MS,Marsden PA.Epigenetics and cardiovascular disease[J].Can J Cardiol,2013,29(1):46-57.
[2]
Fazzari MJ,Greally JM.Introduction to epigenomics and epigenome-wide analysis Methods[J].Mol Biol,2010,620:243-265.
[3]
Kundu S,Peterson CL.Role of chromatin states in transcriptional memory[J].Biochim Biophys Acta,2009,1790:445-455.
[4]
Kim JK,Samaranayake M,Pradhan S.Epigenetic mechanisms in mammals[J].Cell Mol Life Sci,2009,66:596-612.
[5]
Herman JG,Baylin SB.Gene silencing in cancer association with promoter hypermethylation[J].N EngI J Med,2003,349(21):2042-2054.
[6]
Bird A.DNA methylation patterns and epigenetic memory [J].Genes Dev,2002,16(1):6-21.
[7]
Davis CD,Uthus E0.DNA Methylation,cancer susceptibility,and nutrient interactions[J].Exp Biol Med(Maywood),2004,229(10):988-995.
[8]
Krista S.Crider,3,Thomas P,et al.Folate and DNA Methylation:A Review of Molecular Mechanisms and the Evidence for Folate's Role[J].Adv Nutr,2012,3(1):21-38.
[9]
Hayette S,Thomas X,Jallades L,et al.High DNA Methyltransferase DNMT3B Levels:A Poor Prognostic Marker in Acute Myeloid Leukemia[J].PLoS One.2012,7(12):e51527.
[10]
Hui Liu,Yifei Jiao,Yana Guan,et al.The DNMT3B-579 G>T promoter polymorphism and risk of lung cancer[J].Exp Ther Med,2012,3(3):525-529.
[11]
Wu SC,Zhang Y.Active DNA demethylation:many roads lead to Rome[J].Nat Rev Mol Cell Biol,2010,11:607-620.
Lund G,Andersson L,Lauria M,et al.DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E[J].J Biol Chem,2004,279(28):29147-29154.
[14]
Kim M,Long TI,Arakawa K,et al.DNA methylation as a biomarker for cardiovascular disease risk [J].PLOS One,2010,5(3):e9692
[15]
Mendelsohn ME,Karas RH.The protective effects of estrogen on the cardiovascular system[J].N Engl J Med,1999,340(34):1801-1811.
[16]
Losordo DW,Kearney M,Kim EA,et al.Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women[J].Circulation,1994,89(4):1501-1510.
[17]
Kortelainen ML,Huttunen P.Expression of estrogen receptors in the coronary arteries of young and premenopausal women in relation to central obesity[J].Int J Obes Relat Metab Disord,2004,28(4):623-627.
[18]
Ying AK,Hassanain HH,Roos CM,et al.Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells[J].Cardiovasc Res,2000,46:172-179.
[19]
Dong C,Yoon W,Goldschmidt-Clermont PJ.DNA methylation and atherosclerosis[J].J Nutr,2002,132(8):2406S-2409S.
[20]
Post WS,Goldschmidt-Clermont PJ,Wilhide CC,et al.Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system [J].Cardiovascular Res,1999,43(4):985-991.
[21]
Huang YS,Zhi YF,Wang SR.Hypermethylation of estrogen receptor-alpha gene in atheromatosis patients and its correlation with homocysteine[J].Pathophysiology,2009,16(4):259-65.
[22]
Lindner V,Kim SK,Karas RH,et al.Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury[J].Circ Res,1998,83(2):224-229.
[23]
Kim J,Kim JY,Song KS,et al.Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence[J].Biochim Biophys Acta,2007,1772(1):72-80.
[24]
Matsuda K,Ruff A,Morinelli TA,et al.Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets[J].Am J Physiol,1994,267(3 Pt 2):H887-H893.
[25]
Zhang XJ,Li XY,Cao TT,et al.Correlation of endogenous androgen and androgen receptor level with coronary artery diseases in elderly males [J].Zhonghua Yi Xue Za Zhi,2011,91(14):984-986.
Zhu S,Goldschmidt-Clermont PJ,Dong C.Inactivation of monocarboxylate transporter MCT3 by DNA methylation in atherosclerosis[J].Circulation,2005,112(9):1353-1361.
Jianhui Zhuang,Wenhui Peng,Hailing Li,et al.Methylation of p15INK4b and Expression of ANRIL on Chromosome 9p21 Are Associated with Coronary Artery Disease[J].PLoS One,2012,7(10):e47193.
